SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.865
-0.065 (-1.65%)
Mar 5, 2026, 9:55 AM EST - Market open

SAB Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
18.74-34.11-42.19-18.74-17.1420.12
Depreciation & Amortization
3.14.793.753.291.650.55
Stock-Based Compensation
2.722.942.422.672.311.3
Other Adjustments
-63.84-5.628.58-10.453.48-0
Change in Receivables
-0.46-0.055.562.4512.56-17.75
Changes in Accounts Payable
1.750.92-2.7-0.78-2.945.21
Changes in Accrued Expenses
-0.1-1.23-1.71-2.543.381.41
Changes in Other Operating Activities
0.56-1.941.190.63-1.32-0.83
Operating Cash Flow
-37.53-34.29-25.12-23.461.9910
Operating Cash Flow Growth
-----80.14%-
Capital Expenditures
-0.06-0.34-0.2-2.17-10.94-12.73
Sale of Property, Plant & Equipment
0-0.040.08-0.01
Purchases of Investments
-131.3-37.45----
Proceeds from Sale of Investments
20.6925.82----
Investing Cash Flow
-110.67-11.96-0.15-2.09-10.94-12.72
Long-Term Debt Issued
-0.520.771.242.840.66
Long-Term Debt Repaid
-0.28-1.29-1.03-2.26-1.09-1.4
Net Long-Term Debt Issued (Repaid)
-0.28-0.77-0.26-1.021.75-0.74
Issuance of Common Stock
-00.020.017.7634.359.9
Repurchase of Common Stock
-0.03-0.02----
Net Common Stock Issued (Repurchased)
-0.03-00.017.7634.359.9
Issuance of Preferred Stock
--67.15---
Net Preferred Stock Issued (Repurchased)
--67.15---
Other Financing Activities
-0.15-0.39-0.13-5.68-0.2-0.18
Financing Cash Flow
-0.17-1.1766.771.0535.898.98
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-0.1-0.240.02---
Net Cash Flow
20.25-47.6741.52-24.526.936.26
Free Cash Flow
-37.59-34.63-25.32-25.63-8.96-2.73
FCF Margin
-32769.84%-2618.65%-1130.71%-107.20%-14.71%-4.94%
Free Cash Flow Per Share
-1.42-3.74-4.59-5.89-3.28-1.01
Levered Free Cash Flow
24.24-32.67-42.14-21.33-25.5613
Unlevered Free Cash Flow
-37.93-40.7-37.76-30.44-23.5614.17
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q